180 related articles for article (PubMed ID: 7002122)
1. [Fendiline hydrochloride as a therapeutic agent in chronic coronary insufficiency].
Vichi FL
Arq Bras Cardiol; 1980 Apr; 34(4):327-30. PubMed ID: 7002122
[No Abstract] [Full Text] [Related]
2. [Comparative study of verapamil and fendiline in the treatment of chronic coronary insufficiency. Clinical and ergometric evaluation].
Candau LA; Pereira LS; Lavall MA; Carvalho CR
Arq Bras Cardiol; 1982 Aug; 39(2):135-8. PubMed ID: 6763518
[No Abstract] [Full Text] [Related]
3. [Cycloergometric evaluation of fendiline in chronic coronary insufficiency].
Armaganijan D; Batlouni M; de Araújo JR
Arq Bras Cardiol; 1979 Sep; 33(3):225-8. PubMed ID: 396912
[No Abstract] [Full Text] [Related]
4. [Effects of fendiline in myocardial ischemia of exertion].
Richichi I; Massacci E; Collarini L; Codega S; Venturini C; Lorenzi A
Cardiologia; 1985 Mar; 30(3):229-33. PubMed ID: 4064073
[No Abstract] [Full Text] [Related]
5. [Outpatient polyclinic observations on senzit in the treatment of ischemic heart disease].
Kokutsov A
Vutr Boles; 1990; 29(1):35-8. PubMed ID: 2396416
[TBL] [Abstract][Full Text] [Related]
6. [Fendiline (Sensit) in the treatment of coronary disease].
Bała T; Gajewska B; Adamska-Dyniewska H
Wiad Lek; 1983 Apr; 36(7):525-30. PubMed ID: 6349131
[No Abstract] [Full Text] [Related]
7. [Treatment of patients with ischemic heart diseases using senzit].
Zamotaev IP; Venediktova MG; Zakharova GIu
Klin Med (Mosk); 1988 Aug; 66(8):68-71. PubMed ID: 3193737
[No Abstract] [Full Text] [Related]
8. [Clinical evaluation of fendiline as a coronary drug].
Adamska-Dyniewska H; Rosiek S; Dziekański S; Brzozowski R
Pol Tyg Lek; 1988 Feb; 43(6):188-91. PubMed ID: 3043400
[No Abstract] [Full Text] [Related]
9. [Effectiveness of fendiline in ischemic heart disease].
Zochowski RJ; Rdzanek H; Sobieszczańska M; Kochmański M
Pol Tyg Lek; 1988 Apr; 43(16):517-20, 523. PubMed ID: 3045778
[No Abstract] [Full Text] [Related]
10. [Effect of Sensit on central hemodynamics in patients with ischemic heart disease].
Kliuka GR; Sinitsa KI; Okhon'ko VI; Sinitsa TN; Pilipchuk LR
Vrach Delo; 1987 Nov; (11):19-20. PubMed ID: 3439113
[No Abstract] [Full Text] [Related]
11. [Comparative study of the activity of fendiline and nifedipine in ischemic heart disease].
Bertazzoni G; Migliau G; Pantani E; De Castro S; Rosini A
Minerva Cardioangiol; 1985 Apr; 33(4):169-75. PubMed ID: 4047408
[No Abstract] [Full Text] [Related]
12. Observations made with Sensit in the treatment of angina pectoris patients.
Keller L; Landi A
Ther Hung; 1983; 31(4):176-80. PubMed ID: 6400457
[No Abstract] [Full Text] [Related]
13. [Fendiline: clinical advantages].
Belz GG
Fortschr Med Suppl; 1986; 3():14-5. PubMed ID: 2870962
[No Abstract] [Full Text] [Related]
14. [Effects of nitroglycerin on exercise hemodynamics in patients with coronary heart disease under treatment with beta-blockers (mepindolol, oxprenolol) and a calcium-antagonist (fendiline) (author's transl)].
Reiterer W
Wien Med Wochenschr; 1980 Dec; 130(23):772-7. PubMed ID: 6111161
[TBL] [Abstract][Full Text] [Related]
15. [Effect of sensit on the course of ischemic heart disease].
Nesvetov VN; Gorshkov VA; Kuliamin VI; Buskin VD
Sov Med; 1988; (3):57-61. PubMed ID: 3413552
[No Abstract] [Full Text] [Related]
16. [Fendiline brings oxygen to the myocardium].
von Bock und Polach U
Med Klin; 1981 Sep; 76(19):541-4. PubMed ID: 7024764
[No Abstract] [Full Text] [Related]
17. [Role of calcium antagonists in therapy of coronary heart disease. Experimental report on the calcium antagonist fendiline, and the beta receptor blockader metoprolol].
Ardjah H
Med Welt; 1980 Sep; 31(37):1326-30. PubMed ID: 7432128
[No Abstract] [Full Text] [Related]
18. [Type II diabetes and ischemic cardiopathy. Clinical results and possible pharmacologic interference in treatment with fendiline].
Ferraris GM; Barberis G
G Clin Med; 1984; 65(7-8):357-66. PubMed ID: 6500212
[No Abstract] [Full Text] [Related]
19. Use of Sensit, a Ca++ antagonist, in ischaemic heart diseases.
Antalóczy Z; Préda I
Ther Hung; 1979; 27(2):71-6. PubMed ID: 494143
[No Abstract] [Full Text] [Related]
20. [Changes in intracardiac hemodynamics and the tolerance for physical loading as affected by Nitrong in persons suffering from ischemic heart disease].
Gasilin VS; Shevchenko OP; Maksumov EIu; Lupanov VP
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1981; 4(1):59-64. PubMed ID: 6789850
[No Abstract] [Full Text] [Related]
[Next] [New Search]
